
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. Keeping that in mind, here is one profitable company that balances growth and profitability and two best left off your watchlist.
Two Stocks to Sell:
Camping World (CWH)
Trailing 12-Month GAAP Operating Margin: 2.3%
Founded in 1966 as a single recreational vehicle (RV) dealership, Camping World (NYSE: CWH) still sells RVs along with boats and general merchandise for outdoor activities.
Why Do We Pass on CWH?
- Poor same-store sales performance over the past two years indicates it’s having trouble bringing new shoppers into its brick-and-mortar locations
- Performance over the past three years was negatively impacted by new share issuances as its earnings per share dropped by 67.5% annually, worse than its revenue
- 8× net-debt-to-EBITDA ratio makes lenders less willing to extend additional capital, potentially necessitating dilutive equity offerings
Camping World’s stock price of $4.54 implies a valuation ratio of 9.7x forward P/E. Check out our free in-depth research report to learn more about why CWH doesn’t pass our bar.
Amneal (AMRX)
Trailing 12-Month GAAP Operating Margin: 14.6%
Founded in 2002 and growing into one of America's largest generic drug producers, Amneal Pharmaceuticals (NASDAQ: AMRX) develops, manufactures, and distributes generic medicines, specialty branded drugs, biosimilars, and injectable products for the U.S. healthcare market.
Why Does AMRX Fall Short?
- Estimated sales growth of 3.3% for the next 12 months implies demand will slow from its two-year trend
- Annual earnings per share growth of 4.8% underperformed its revenue over the last five years, showing its incremental sales were less profitable
- Underwhelming 6.1% return on capital reflects management’s difficulties in finding profitable growth opportunities
Amneal is trading at $20.23 per share, or 19.8x forward P/E. Read our free research report to see why you should think twice about including AMRX in your portfolio.
One Stock to Buy:
Netflix (NFLX)
Trailing 12-Month GAAP Operating Margin: 29.7%
Launched by Reed Hastings as a DVD mail rental company until its famous pivot to streaming in 2007, Netflix (NASDAQ: NFLX) is a pioneering streaming content platform.
Why Is NFLX a Top Pick?
- Has the opportunity to boost monetization through new features and premium offerings as its global streaming paid memberships have grown by 15.1% annually over the last two years
- Healthy EBITDA margin of 31.2% shows it’s a well-run company with efficient processes, and it turbocharged its profits by achieving some fixed cost leverage
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 50% exceeded its revenue gains over the last three years
At $70.77 per share, Netflix trades at 16.5x forward EV/EBITDA. Is now the right time to buy? See for yourself in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
